A preliminary study of the effects of cyclandelate.
D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000627:therapeutic use*; D004185:Disability Evaluation; D006801:Humans; D008333:Mandelic Acids / Q000627:therapeutic use*; D008606:Mental Processes; D009461:Neurologic Manifestations
D003510:Cyclohexanes; D008333:Mandelic Acids